The Rising Cost of Living Is Becoming a Mental Health Crisis for Young Employees
Modern Health's new workplace report finds 75% blame financial stress for fueling burnout and hurting productivity, 79% sacrifice mental health to meet work demands and 96% want preventative mental health support
Article content
SAN FRANCISCO — A new report from Modern Health, a global premium mental health solution provider, reveals a troubling picture of how Gen Z and Millennial employees are faring: only 16% rate their current mental health as excellent, with the vast majority grappling with anxiety fueled by economic uncertainty and financial stress that is taxing work productivity and personal time. In a survey of 1,000 American professionals aged 18 to 44, 79% not only feel anxious from economic uncertainty, concerningly they are also sacrificing their mental health to meet work demands.
Article content
Article content
'Our latest report reveals that many of today's young workers are quietly pushing through mounting mental health challenges just to keep up at work,' said Matt Levin, CEO of Modern Health. 'They're not getting the support they need, which should be a wake-up call for employers. We can't afford to wait until someone is in crisis to act—we need to meet people earlier, with care that's proactive, adaptive, and designed to support the mental health of entire workforce populations.'
Article content
Anxiety is the New Cost of Living
Article content
Financial anxiety and economic uncertainty are a key driver of mental health challenges for today's employees. Three in four say financial stress is fueling their burnout and hurting their productivity, 76% say financial anxiety is disrupting their sleep, mood and energy and directly impacting their productivity at work, and 68% say financial anxiety regularly interferes with their ability to do their jobs effectively.
Article content
Financial and economic concerns are also dissuading employees from taking positive professional and personal actions in their lives. A resounding 74% of employees say they've delayed taking time off work due to financial concerns, while more than half (55%) have postponed seeking mental health care for the same reason. Even more concerning, 69% say they're staying in toxic job environments or avoiding necessary career changes due to economic fears.
Article content
Repercussions of Hustle Culture
Article content
The report reveals a troubling level of skepticism among younger employees when it comes to their employers' commitment to mental health. A striking 71% believe their employer uses mental health initiatives to mask a toxic culture, while 61% describe their company culture as flawed. Over half (53%) say their employer encourages self-care but makes it nearly impossible to practice.
Article content
This erosion of trust is potentially fueling an unhealthy pace of work and worsening mental health in the workplace. A high majority (79%) say they routinely sacrifice their mental health to keep up with work demands, and 77% admit to checking emails during PTO, or avoiding time off altogether for fear of falling behind. Even when employees do take time off, 68% report feeling guilty, worrying it will be viewed as unproductive, or admit feeling pressure to 'power through.' Just 21% of employees say they can truly unplug without pressure from work. Alarmingly, 77% say they've worked through a mental health crisis because they felt they couldn't take a break.
Article content
'The disconnect employees feel between their mental health needs and the realities of the workplace is a signal—not of failure, but of opportunity,' said Dr. Jessica Watrous, Senior Director of Clinical Research & Scientific Affairs at Modern Health. 'Many employers are doing their best to support well-being, but employees are still feeling pressure to be 'always on,' even when it impacts their health. By creating cultures that enable people to truly unplug and ask for help without guilt, organizations can build the kind of trust and resilience that helps both people and businesses thrive—especially in today's unpredictable environment.'
Article content
The Mental Health Care Gap and the High Cost of Inaction
Article content
One of the most urgent challenges in workplace mental health today is the gap between when employees need support and when they actually receive it. The desire for early access to resources—before one is in crisis—is widespread, with a staggering 96% wanting access to preventative mental health support as a workplace benefit and 94% stating that they believe it would make a positive difference in their work lives. Spotlighting the growing care gap, 58% of employees admit they've waited until symptoms became unmanageable before getting help.
Article content
The incentive for employers to close this gap is clear. Employees overwhelmingly believe access to preventative support would make a meaningful difference: 52% say they would feel more positive about their company, 51% say it would boost their productivity, and 49% believe it would help them avoid burnout altogether. And it's not just employees—99% of Gen Z and Millennial managers agree that workforce mental health programs positively impact overall business goals with almost half (49%) stating they directly influence business performance and results.
Article content
For companies that fail to meet these needs, the stakes are high. More than half (52%) of respondents say they've considered quitting their job to protect their mental health—a clear signal that action is no longer optional. Worryingly, 1 in 7 young workers are actively searching for a new job for this very reason.
Article content
'It's not surprising to hear that younger employees want mental health support before they're in crisis—it's something we see every day,' said Alison Borland, Modern Health's Chief People and Strategy Officer. 'For many, caring for their mental health is part of how they stay balanced and show up at work and in life—and they expect their employer to support that. Mental health can't just be treated as a problem to fix after it escalates. It needs to be a strategic priority, which means offering proactive, personalized support that evolves with people's needs. At Modern Health, we call this adaptive care—and it's not only the right thing to do for employees, it's a proven way to retain top talent and reduce healthcare costs.'
Article content
To learn more, download the full report here.
Article content
About Modern Health
Article content
Modern Health is a global leader in adaptive mental health care, dynamically offering multi-modal mental health support that delivers meaningful outcomes at a sustainable, predictable cost. With therapy, psychiatry, coaching, community groups, self-guided tools, and crisis support we dynamically create individualized care journeys to address a spectrum of mental health needs and preferences with culturally responsive providers in 200+ countries and territories and 80+ languages. Backed by peer-reviewed research and a proprietary blend of technology and live support, Modern Health delivers measurable outcomes, globally equitable access, and sustainable pricing. Our industry-leading Adaptive Care Model and dedicated, human centered, operationally tuned, customer success partners make us a trusted partner for organizations worldwide.
Article content
Visit us at http://modernhealth.com to learn how we can help you optimize your people and your business.
Article content
Methodology
Article content
Modern Health commissioned this scientific random sample of 1,000 U.S. adults (aged 18-44). This group was surveyed between June 5, 2025 and June 6, 2025. All respondents are currently employed for wages, confirmed by consumer-matched data. Sampling was calibrated to obtain a representative demographic sample aligned with U.S. workforce statistics. DKC Analytics conducted and analyzed this survey with a sample procured using the Pollfish survey delivery platform, which delivers online surveys globally through mobile apps and the mobile web along with the desktop web. No post-stratification has been applied to the results.
Article content
Article content
Article content
Article content
Article content
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
an hour ago
- Globe and Mail
Psychedelic Pharma Stock Surges on FDA Breakthrough
The psychedelic pharmaceutical sector continues gaining mainstream acceptance as regulatory barriers fall and medical applications expand beyond traditional treatments. With mental health disorders reaching epidemic proportions and conventional therapies showing limited efficacy for many patients, regulators are increasingly open to alternative treatments that were once considered fringe. This paradigm shift has created significant opportunities for companies positioned at the intersection of established pharmaceutical development and emerging psychedelic therapeutics. Shares of PharmaTher Holdings Ltd. (OTCQB: PHRRF) (CSE: PHRM) are moving higher in Monday afternoon trading following the announcement that the company received FDA approval for its ketamine product, KETARx™, on August 8th for surgical pain management applications. This milestone represents a significant breakthrough for the specialty pharmaceutical company focused on unlocking ketamine's therapeutic potential across multiple medical conditions. The FDA approval positions PharmaTher to capitalize on the rapidly expanding ketamine market, which is currently valued at $750 million and projected to reach $3.42 billion by 2034, representing a compound annual growth rate of 16.4%. Ketamine stands out among psychedelic compounds as the only one included on the World Health Organization's Model List of Essential Medicines, providing additional validation for its therapeutic applications. The approval comes at an opportune time, as ketamine has been regularly listed on the FDA drug shortage list since February 2018, highlighting significant supply challenges in the market. The FDA has also issued compounding risk alerts regarding potential safety issues with non-approved ketamine products, creating demand for high-quality, FDA-approved alternatives like KETARx™. PharmaTher's FDA approval provides a strong foundation for expanding ketamine development across diverse therapeutic areas within the company's pipeline, including mental health conditions like depression, neurological disorders such as Parkinson's disease and ALS, and chronic pain management including Complex Regional Pain Syndrome. The market potential is demonstrated by SPRAVATO (esketamine), an FDA-approved depression treatment currently tracking a $1.6 billion sales run rate with guidance projecting $3 billion to $3.5 billion by 2027-2028. Additionally, the Veterans Health Administration currently approves and funds ketamine infusions for retired military personnel with depression, PTSD, and chronic pain, indicating established institutional acceptance. "Today marks a new chapter for PharmaTher," commented CEO Fabio Chianelli. "With FDA approval for ketamine now in hand, we are closer to realizing our goal of becoming a global leader in ketamine-based pharmaceuticals. This historic FDA approval for PharmaTher is a testament to years of dedicated development, signaling a new era of growth." U.S. shares of PHRRF are up 8.6% at $0.39, while Canadian shares of PHRM are ahead 8.0% at C$0.54 in Monday afternoon trading. Copyright © 2025 All rights reserved. Republication or redistribution of content is expressly prohibited without the prior written consent of shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. View more of this article on About Media, Inc.: Founded in 1999, is one of North America's leading platforms for micro-cap insights. Catering to both Canadian and U.S. markets, we provide a wealth of resources and expert content designed for everyone—from beginner investors to seasoned traders. is rapidly gaining recognition as a leading authority in the micro-cap space, with our insightful content prominently featured across numerous top-tier financial platforms, reaching a broad audience of investors and industry professionals. Want to showcase your company's story to a powerful network of investors? We can help you elevate your message and make a lasting impact. Contact us today. Contact: Media, Inc.
National Post
3 hours ago
- National Post
Modern Health Welcomes New Chief Technology Officer and General Counsel
Article content New Data from Modern Health Reinforces Proven Model and Offers Fresh Insight into Evolving Workforce Needs Article content SAN FRANCISCO — Modern Health, a leading global workplace mental health platform, today announced the appointments of Chen Cheng as Chief Technology Officer and Erin Brown as General Counsel, along with other company momentum, as it accelerates its mission to make mental health care more accessible, personalized, and effective worldwide. Article content In her role as Chief Technology Officer, Chen Cheng will oversee the company's technology and further scale the platform to provide high-quality, clinically rigorous care across the globe. She brings more than a decade of experience in the health technology sector to Modern Health, including roles at Oscar Health and ZocDoc. As technology plays an increasingly critical role in expanding access to mental health care and support, evidenced by the growing engagement with virtual therapy, coaching, and digital tools, Chen will leverage her tech experience and leadership to help Modern Health advance its innovations. Article content Erin Brown joins Modern Health as General Counsel, bringing more than 20 years of legal experience across the health and benefits space. Brown has amassed a proven track record of guiding high-growth organizations through complex legal and regulatory environments. Prior to Modern Health, Brown was Senior Vice President and Associate General Counsel at Alight Solutions and, before that, Associate General Counsel at Aon Hewitt. Her expertise and strategic counsel will be key as Modern Health continues to expand its global footprint and innovate responsibly in a rapidly evolving industry. Article content 'Welcoming exceptional leaders like Chen and Erin marks an exciting step forward for Modern Health,' said Matt Levin, CEO of Modern Health. 'They each bring a powerful combination of industry expertise and a passion for making mental health care more accessible, personalized, and effective. Their leadership will accelerate our momentum as we scale our impact, drive innovation, and continue delivering meaningful outcomes for the workplaces we support worldwide.' Article content In addition to these appointments, other recent company momentum includes: Article content Modern Health has been named to the 2025 Inc. 5000 list of the fastest-growing private companies in America. The list highlights companies that have demonstrated significant revenue growth over a three-year period and serves as a benchmark for entrepreneurial success and a platform for recognizing the contributions of these businesses to the US economy. Modern Health launches ROI Study that proves mental health care pays off: According to a third-party analysis of 13,000+ members, the most significant savings (60% of total savings) in health care spend for employers come from reaching more employees earlier with support that fits their needs before symptoms escalate. Modern Health's evidence-based Adaptive Care Model delivers an estimated $2.39 return for every dollar invested, based solely on health care cost savings. These compelling findings underscore how Modern Health's Adaptive Care Model improves outcomes and drives down costs by supporting the whole workforce—not just those with severe mental health concerns. Peer-reviewed data shows Modern Health's global mental health model works anywhere: In one of the largest and most diverse real-world studies of its kind, Modern Health examined engagement and clinical outcomes among more than 33,000 members across seven global regions to understand not only how mental health needs vary across regions but also whether a single care model could truly work at a global scale. The study proves that achieving global scale requires more than a one-size-fits-all approach; it demands an adaptive, evidence-based model designed to deliver meaningful results across diverse regions and populations. Modern Health's latest study paints a stark picture of how Gen Z and Millennial employees are faring: In a study of 1,000 American professionals aged 18 to 44, the findings reveal a generation silently struggling under the weight of burnout, financial anxiety, and workplace systems that haven't kept pace with their needs. Among the most striking statistics: 75% blame financial stress for fueling burnout and hurting productivity, 79% sacrifice mental health to meet work demands, and 96% want access to preventative mental health support. The workplace report highlights a troubling reality: too many young workers are quietly pushing through mounting mental health challenges just to keep up at work, underscoring the urgent need to meet people earlier, with care that's proactive, adaptive, and designed to support the mental health of entire workforce populations. Launch of FlexEAP Challenges Outdated Employee Assistance Programs: Modern Health recently launched FlexEAP ('Flex'), a next-gen Employee Assistance Program (EAP) addressing the critical shortcomings of traditional EAPs by delivering rapid access to care, adaptive support extending far beyond crisis intervention, and a seamless, consistent global experience. The product combines Modern Health's Adaptive Care Model with an elite, global provider network to deliver a seamless, personalized mental health experience. Employees can access care, on average, within 24 hours, with fast, frictionless support across therapy, coaching, crisis intervention, and digital self-guided tools. Flex delivers superior outcomes and an upgraded, consumer-grade experience compared to traditional EAPs, while offering flexible pricing, customizable solutions, and risk-sharing based on utilization—empowering employers to better manage costs. Expanded Languages for Pathways: Modern Health is proud to offer its Pathways Collections, offering tailored one-on-one support around a variety of topics, including Workplace Well-being, Family Care, and Physical Well-Being, as a truly multilingual product. Now, members can connect with a Pathway Provider in six additional languages — Spanish, Dutch, Hindi, Portuguese, Japanese, and French. Article content About Modern Health Article content Modern Health is a global leader in adaptive mental health care, dynamically offering multi-modal mental health support that delivers meaningful outcomes at a sustainable, predictable cost. With therapy, psychiatry, coaching, community groups, self-guided tools, and crisis support, we dynamically create individualized care journeys to address a spectrum of mental health needs and preferences with culturally responsive providers in 200+ countries and territories and 80+ languages. Backed by peer-reviewed research and a proprietary blend of technology and live support, Modern Health delivers measurable outcomes, globally equitable access, and sustainable pricing. Our industry-leading Adaptive Care Model and dedicated, human centered, operationally tuned, customer success partners make us a trusted partner for organizations worldwide. Article content Article content Article content Article content Article content
CTV News
3 hours ago
- CTV News
Tennis star Monica Seles reveals her diagnosis with myasthenia gravis
International Tennis Hall of Fame inductee Monica Seles waves to the crowd as she holds her plaque during ceremonies in Newport, R.I., July 11, 2009. (AP Photo/Elise Amendola) Monica Seles first noticed the symptoms of myasthenia gravis — a neuromuscular autoimmune disease she discussed during a recent interview with The Associated Press — while she was swinging a racket the way she'd done so many times during, and after, a career that included nine Grand Slam titles and a place in the International Tennis Hall of Fame. 'I would be playing with some kids or family members, and I would miss a ball. I was like, 'Yeah, I see two balls.' These are obviously symptoms that you can't ignore,' Seles said. 'And, for me, this is when this journey started. And it took me quite some time to really absorb it, speak openly about it, because it's a difficult one. It affects my day-to-day life quite a lot.' The 51-year-old Seles, who won her first major trophy at age 16 at the 1990 French Open and played her last match in 2003, said she was diagnosed with myasthenia gravis three years ago and is speaking publicly about it for the first time ahead of the U.S. Open, which starts on Aug. 24, to raise awareness about what is known as MG. The National Institute of Neurological Disorders and Stroke calls it 'a chronic neuromuscular disease that causes weakness in the voluntary muscles' and 'most commonly impacts young adult women (under 40) and older men (over 60) but ... can occur at any age, including childhood.' Seles said she'd never heard of the condition until seeing a doctor and being referred to a neurologist after noticing symptoms such as double vision and weakness in her arms — 'just blowing my hair out ... became very difficult,' she said — and legs. 'When I got diagnosed, I was like, 'What?!'' said Seles, who is partnering with argenx, an immunology company headquartered in the Netherlands, to promote their Go for Greater campaign. 'So this is where — I can't emphasize enough — I wish I had somebody like me speak up about it.' It's been three decades since Seles returned to competition at the 1995 U.S. Open, making it to the final, more than two years after she was attacked by a man with a knife at a tournament in Hamburg, Germany. 'The way they welcomed me ... after my stabbing, I will never forget,' Seles said about the fans in New York. 'Those are the moments that stay with you.' She talks about learning to live a 'new normal' nowadays and characterized her health as another in a series of life steps that required adapting. 'I had to, in tennis terms, I guess, reset — hard reset — a few times. I call my first hard reset when I came to the U.S. as a young 13-year-old (from Yugoslavia). Didn't speak the language; left my family. It's a very tough time. Then, obviously, becoming a great player, it's a reset, too, because the fame, money, the attention, changes (everything), and it's hard as a 16-year-old to deal with all that. Then obviously my stabbing — I had to do a huge reset," Seles said. 'And then, really, being diagnosed with myasthenia gravis: another reset. But one thing, as I tell kids that I mentor: 'You've got to always adjust. That ball is bouncing, and you've just got to adjust,'' she added. 'And that's what I'm doing now.' ___ Howard Fendrich has been the AP's tennis writer since 2002. Find his stories here: More AP tennis: Howard Fendrich, The Associated Press
